Literature DB >> 16546482

Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.

Charles J Glueck1, John A Morrison, Lisa Aronson Friedman, Naila Goldenberg, Davis M Stroop, Ping Wang.   

Abstract

Adolescent girls with polycystic ovary syndrome (PCOS) have increased levels of factors constituting the metabolic syndrome: centripetal obesity, hypertension, hypertriglyceridemia, low high-density lipoprotein cholesterol (HDL-C), and hyperinsulinemia. Given the strong association reported between early, persistent obesity and development of metabolic syndrome 10 years later in girls, we speculated that if adolescent girls without PCOS had obesity measures similar to girls with PCOS, they would exhibit similar metabolic syndrome-cardiovascular disease risk factors. Within this context, we compared 37 adolescent girls with PCOS and 2 samples of normal, regularly cycling adolescent girls (controls) of similar ages, selected from the Cincinnati Clinic of the National Heart, Lung, and Blood Institute Growth and Health Study. The first sample included 157 controls selected using a stratified random sample based on age. As expected, girls with PCOS had higher body mass index (BMI), waist circumference, insulin, systolic blood pressure (SBP) and diastolic blood pressure, triglycerides (TGs), lower HDL-C, and higher low-density lipoprotein cholesterol (LDL-C) and free testosterone (FT) than controls. A second sample consisted of girls matched one to one with girls with PCOS for BMI and age. Comparisons of group differences were not significant for insulin, lipids, or blood pressure; girls with PCOS had a trend toward higher values for waist circumference (median, 92.7 vs 87.5 cm; P = .07) and much higher median FT (4.25 vs 1.42 ng/mL, P = .0001). After matching for BMI and age, by conditional regression analysis, we showed that the groups were not differentiated (P > .15) by insulin, HDL-C, LDL-C, TG, SBP, or diastolic blood pressure, but were differentiated by higher FT (P = .0024) and waist circumference (P = .0024) in PCOS than in controls. Prospective longitudinal analyses of NHGS controls showed that changes in BMI from ages 9 to 10 years to ages 15 to 16 years were positively associated with changes in waist circumference (P < .0001), LDL-C (P = .01), TG (P = .008), and SBP (P = .002). These findings suggest that if adolescent girls achieve adiposity equal to girls with PCOS, they then acquire major components of the metabolic syndrome, and excluding high FT and waist circumference, comparable increased cardiovascular disease risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16546482     DOI: 10.1016/j.metabol.2005.11.003

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  17 in total

1.  Interventional studies for polycystic ovarian syndrome in children and adolescents.

Authors:  Patricia Myriam Vuguin
Journal:  Ped Health       Date:  2010-02

2.  Prevalence of polycystic ovary syndrome in adolescents.

Authors:  Shawna B Christensen; Mary Helen Black; Ning Smith; Mayra M Martinez; Steve J Jacobsen; Amy H Porter; Corinna Koebnick
Journal:  Fertil Steril       Date:  2013-06-05       Impact factor: 7.329

Review 3.  Polycystic ovary syndrome in adolescence: diagnostic and therapeutic strategies.

Authors:  Manmohan K Kamboj; Andrea E Bonny
Journal:  Transl Pediatr       Date:  2017-10

4.  Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers.

Authors:  Sonali S Patel; Uyen Truong; Martina King; Annie Ferland; Kerrie L Moreau; Jennifer Dorosz; John E Hokanson; Hong Wang; Gregory L Kinney; David M Maahs; Robert H Eckel; Kristen J Nadeau; Melanie Cree-Green
Journal:  Vasc Med       Date:  2017-01-17       Impact factor: 3.239

5.  A randomized pilot study of dietary treatments for polycystic ovary syndrome in adolescents.

Authors:  J M W Wong; M Gallagher; H Gooding; H A Feldman; C M Gordon; D S Ludwig; C B Ebbeling
Journal:  Pediatr Obes       Date:  2015-07-01       Impact factor: 4.000

Review 6.  Diagnosis and challenges of polycystic ovary syndrome in adolescence.

Authors:  Sophia E Agapova; Tamara Cameo; Aviva B Sopher; Sharon E Oberfield
Journal:  Semin Reprod Med       Date:  2014-04-08       Impact factor: 1.303

7.  Mood and Ambulatory Monitoring of Physical Activity Patterns in Youth with Polycystic Ovary Syndrome.

Authors:  Julie C Michael; Nermeen E El Nokali; Jessica J Black; Dana L Rofey
Journal:  J Pediatr Adolesc Gynecol       Date:  2014-11-15       Impact factor: 1.814

Review 8.  Menstrual health and the metabolic syndrome in adolescents.

Authors:  Hala Tfayli; Silva Arslanian
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

9.  Impact of metformin monotherapy versus metformin with oestrogen-progesterone on lipids in adolescent girls with polycystic ovarian syndrome.

Authors:  Miriam A Bredella; Shilpa McManus; Madhusmita Misra
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04-01       Impact factor: 3.478

10.  Early Biomarkers of Subclinical Atherosclerosis in Obese Adolescent Girls with Polycystic Ovary Syndrome.

Authors:  Kara S Hughan; Hala Tfayli; Julia G Warren-Ulanch; Emma Barinas-Mitchell; Silva A Arslanian
Journal:  J Pediatr       Date:  2015-11-03       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.